...
首页> 外文期刊>The Journal of Physiology >Pathways involved in gut mucosal barrier dysfunction induced in adult rats by maternal deprivation: corticotrophin-releasing factor and nerve growth factor interplay.
【24h】

Pathways involved in gut mucosal barrier dysfunction induced in adult rats by maternal deprivation: corticotrophin-releasing factor and nerve growth factor interplay.

机译:母体剥夺对成年大鼠肠黏膜屏障功能障碍的影响:促肾上腺皮质激素释放因子和神经生长因子的相互作用。

获取原文
获取原文并翻译 | 示例
           

摘要

Neonatal maternal deprivation (NMD) increases gut paracellular permeability (GPP) through mast cells and nerve growth factor (NGF), and modifies corticotrophin-releasing factor (CRF) and corticosterone levels. CRF, corticosterone and mast cells are involved in stress-induced mucosal barrier impairment. Consequently, this study aimed to specify whether corticosteronaemia and colonic expression of both preproCRF and CRF are modified by NMD, and to determine if altered expression may participate in the elevated GPP in connection with NGF and mast cells. Male Wistar rat pups were either separated from postnatal days 2-14, or left undisturbed with their dam. At 12 weeks of age, adult rats were treated with mifepristone (an antagonist of corticoid receptors), alpha-helical CRF((9-41)) (a non-specific CRF receptor antagonist), or SSR-125543 (CRF-R(1) receptor antagonist). We also determined corticosteronaemia and both colonic preproCRF and CRF expression. Then, control rats were treated by CRF, doxantrazole (mast cell stabilizer), BRX-537A (a mast cell activator) and anti-NGF antibody. NMD did not modify colonic CRF level but increased colonic preproCRF expression and corticosteronaemia. Peripheral CRF, via CRF-R(1) receptor, but not corticosterone, was involved in the elevated GPP observed in these rats, through a mast-cell-mediated mechanism, since the increase of GPP induced by exogenous CRF was abolished by doxantrazole. Anti-NGF antibody treatment also reduced the elevated GPP induced by CRF or BRX-537A. CRF acts through CRF-R(1) receptors to stimulate NGF release from mast cells, which participates in the elevated GPP observed in NMD adult rats. This suggests that early traumatic experience induced neuro-endocrine dysfunction, involved in alterations of gut mucosal barrier.
机译:新生儿母体剥夺(NMD)通过肥大细胞和神经生长因子(NGF)增加肠道副细胞通透性(GPP),并修饰促肾上腺皮质激素释放因子(CRF)和皮质酮水平。 CRF,皮质酮和肥大细胞参与应激诱导的粘膜屏障损伤。因此,这项研究旨在确定NMD是否能改变前proCRF和CRF的糖皮质激素血症和结肠表达,并确定改变的表达是否可能参与与NGF和肥大细胞有关的GPP升高。雄性Wistar大鼠幼崽从出生后2-14天开始分离,或者不受其母坝干扰。在12周龄时,成年大鼠接受米非司酮(皮质类固醇受体拮抗剂),α-螺旋CRF((9-41))(非特异性CRF受体拮抗剂)或SSR-125543(CRF-R( 1)受体拮抗剂)。我们还确定了皮质激素血症以及结肠preproCRF和CRF的表达。然后,对对照组大鼠进行CRF,阿霉素(肥大细胞稳定剂),BRX-537A(肥大细胞激活剂)和抗NGF抗体治疗。 NMD不会改变结肠的CRF水平,但会增加结肠的proproCRF表达和糖皮质激素血症。通过肥大细胞介导的机制,通过CRF-R(1)受体而不是皮质类固醇的外周CRF参与了在这些大鼠中观察到的升高的GPP,这是由于阿森酸消除了外源CRF诱导的GPP升高。抗NGF抗体治疗还降低了CRF或BRX-537A诱导的升高的GPP。 CRF通过CRF-R(1)受体来刺激NGF从肥大细胞中释放,肥大细胞参与了在NMD成年大鼠中观察到的GPP升高。这表明早期的创伤经历引起了神经-内分泌功能障碍,参与了肠粘膜屏障的改变。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号